What is UroGen Pharma's return on equity?

UroGen Pharma (URGN) reported return on equity of -211.6% in Q4 2021.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

UroGen Pharma URGN Return on equity

Discontinued — last reported Q4 '21

Return on equity at other companies

Bristol-Myers SquibbBMY

38.8%+7.3pp

PfizerPFE

10.6%—

Johnson & JohnsonJNJ

26.4%-3.0pp

Merck & Co.MRK

19%-20.3pp

Tyra Biosciences, Inc.TYRA

-36.9%+21.1pp

CG OncologyCGON

-20.8%+7.1pp

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.71B+71.7%

Enterprise value$1.8B+80.9%

P/S12.2×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Calculated from UroGen Pharma’s reported figures.

net income/total stockholders equity=-211.6%

Based on trailing twelve months.

The official record: UroGen Pharma’s 10-K, filed March 24, 2023, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's return on equity?: UroGen Pharma (URGN) reported return on equity of -211.6% in Q4 2021.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.